(19)
(11) EP 1 144 625 A2

(12)

(88) Date of publication A3:
30.11.2000

(43) Date of publication:
17.10.2001 Bulletin 2001/42

(21) Application number: 00905810.8

(22) Date of filing: 28.01.2000
(51) International Patent Classification (IPC)7C12N 15/12, C12Q 1/68, C07K 14/47, C07K 16/18, G01N 33/68, A61K 38/17
(86) International application number:
PCT/US0002/237
(87) International publication number:
WO 0044/900 (03.08.2000 Gazette 2000/31)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 29.01.1999 US 117905 P
29.01.1999 US 117904 P

(71) Applicant: INCYTE PHARMACEUTICALS, INC.
Palo Alto, CA 94304 (US)

(72) Inventors:
  • TANG, Y., Tom
    San Jose, CA 95118 (US)
  • LAL, Pretti
    Santa Clara, CA 95054 (US)
  • HILLMAN, Jennifer, L.
    Mountain View, CA 94040 (US)
  • YUE, Henry
    Sunnyvale, CA 94087 (US)
  • AZIMZAI, Yalda
    Hayward, CA 94545 (US)
  • LU, Aina, M., D.
    San Jose, CA 95136 (US)
  • BAUGHN, Mariah, R.
    San Leandro, CA 94577 (US)
  • TRAN, Bao
    Santa Clara, CA 95051 (US)
  • SHIH, Leo L.
    Palo Alto, CA 94303 (US)
  • AU-YOUNG, Janice, L.
    Brisbane, CA 94005 (US)

(74) Representative: Wright, Simon Mark 
J.A. Kemp & Co.14 South SquareGray's Inn
London WC1R 5JJ
London WC1R 5JJ (GB)

 
Remarks:
WIPO A3 publication data is not currently available.
 


(54) NUCLEIC-ACID BINDING PROTEINS